Accelerating precision drug discovery: Leveraging cloud integration and ai to transform healthcare innovation

Vemuri, Anasuya (2025) Accelerating precision drug discovery: Leveraging cloud integration and ai to transform healthcare innovation. World Journal of Advanced Engineering Technology and Sciences, 15 (3). 019-026. ISSN 2582-8266

[thumbnail of WJAETS-2025-0823.pdf] Article PDF
WJAETS-2025-0823.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download ( 501kB)

Abstract

This article explores how the strategic integration of cloud-based enterprise architectures with Artificial Intelligence is revolutionizing drug discovery by significantly accelerating the development pipeline, enhancing collaborative research, and enabling precision medicine. The pharmaceutical industry faces mounting challenges with traditional drug development approaches, including lengthy timelines, high costs, and substantial failure rates during clinical trials. Cloud-AI integration addresses these challenges through enhanced data processing capabilities, elimination of research silos, and facilitation of global collaboration. By leveraging vast and diverse datasets through cloud platforms and applying AI-driven analytics, healthcare organizations and pharmaceutical companies are transforming the discovery paradigm from serendipitous to data-driven, reducing the time and cost of bringing personalized, effective drugs to market while simultaneously improving candidate molecule quality and success rates across the development continuum.

Item Type: Article
Official URL: https://doi.org/10.30574/wjaets.2025.15.3.0823
Uncontrolled Keywords: Cloud Integration; Artificial Intelligence; Precision Medicine; Drug Discovery; Collaborative Research
Depositing User: Editor Engineering Section
Date Deposited: 16 Aug 2025 12:46
Related URLs:
URI: https://eprint.scholarsrepository.com/id/eprint/4344